A detailed history of Johnson Midwest Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Johnson Midwest Financial, LLC holds 141 shares of ABBV stock, worth $24,064. This represents 0.05% of its overall portfolio holdings.

Number of Shares
141
Previous 141 -0.0%
Holding current value
$24,064
Previous $18,000 16.67%
% of portfolio
0.05%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $1,457 - $1,813
-11 Reduced 7.24%
141 $18,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $1,879 - $2,165
13 Added 9.35%
152 $24,000
Q4 2022

Jan 26, 2023

BUY
$138.31 - $165.87 $6,362 - $7,630
46 Added 49.46%
139 $22,000
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $12,798 - $16,271
93 New
93 $14,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Johnson Midwest Financial, LLC Portfolio

Follow Johnson Midwest Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Midwest Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Midwest Financial, LLC with notifications on news.